Gene Therapy Market to Grow with a CAGR of 9.53% through 2030
Increase in the number of cases of cancer and other chronic diseases is expected to drive the Global Gene Therapy Market growth in the forecast period, 2026-2030.
According to TechSci Research report, “Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2030F”, Global Gene Therapy Market has valued at USD 6.54 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 9.53% through 2030. The market for Gene Therapy devices has witnessed consistent growth over the forecast period due to an increasingly strong product portfolio, expanding investments by key market players, and a high prevalence of target diseases and interest in innovative and new therapy. Furthermore, the increased investment in research and development by government and private organizations will create further prospects for the growth of the gene therapy market during the forecast period. The rapid technological advancements in cellular and molecular biology in genomics research have contributed greatly to the growing gene therapy market in recent years. In many industrialized countries, the frequency of cardiovascular diseases is increasing, and there is a growing need to cure these diseases in less time, resulting in players investing extensively in the research and development of highly effective and innovative therapeutics such as gene therapy. The prevalence of rare diseases such as cardiovascular and cancer diseases will have a positive impact on the demand for gene therapy applications.
Also, technical challenges involve intricate processes of gene delivery, integration, and expression within the target cells which can hamper the growth of Global Gene Therapy Market. Similarly, High Development Costs can restrain the growth of Global Gene Therapy Market. Additionally, Regulatory Hurdles and Limited Manufacturing Scalability will further restrict the growth of Global Gene Therapy Market.
Browse over xx market data Figures spread through xx Pages and an in-depth TOC on "Global Gene Therapy Market.”
The Global Gene Therapy Market is segmented into Vector Type, Delivery Method, Indication and Region.
Based on vector type, the non-viral vector segment is experiencing the fastest growth in the Gene Therapy Market, driven by its numerous advantages over viral vectors. Non-viral vectors offer lower immunogenicity, higher safety profiles, reduced risk of insertional mutagenesis, and cost-effectiveness, making them an attractive alternative for gene delivery. They are widely used in applications such as cancer treatment, genetic disorders, and regenerative medicine, where targeted and efficient gene transfer is crucial. Advancements in nanoparticle-based delivery systems, including lipid nanoparticles (LNPs) and polymer-based carriers, have significantly improved the efficiency of non-viral gene transfer. Additionally, breakthroughs in electroporation and gene-editing technologies like CRISPR-Cas9 are further enhancing the precision and effectiveness of these vectors. The increasing demand for personalized medicine and safer gene therapy solutions has also contributed to their rising adoption. Moreover, growing investments in research and regulatory support for non-viral vector-based gene therapy approaches are accelerating market expansion. As pharmaceutical and biotech companies continue to innovate in this field, the non-viral vector segment is expected to maintain its rapid growth trajectory in the coming years.
Based on the region, the Asia-Pacific region is expected to experience the fastest growth in the Gene Therapy Market over the forecast period. This rapid expansion is driven by increasing investments in biotechnology and healthcare infrastructure, a rising prevalence of genetic disorders, and growing government support for advanced medical treatments. Countries like China, Japan, South Korea, and India are making significant strides in gene therapy research, with a surge in clinical trials and regulatory approvals. Additionally, advancements in non-viral vector technologies, CRISPR-based gene editing, and stem cell research are further fueling market growth in the region. The rising demand for personalized medicine, growing awareness of gene therapies, and an expanding biopharmaceutical industry contribute to the strong momentum. With increasing collaborations between pharmaceutical companies, research institutions, and healthcare providers, the Asia-Pacific region is poised to become a key player in the global gene therapy market.
Major companies operating in Global Gene Therapy Market
are:
- REGENXBIO Inc.
- Oxford Biomedica PLC.
- Voyager Therapeutics Inc.
- Human Stem Cells Institute
- Dimension Therapeutics, Inc.
- Bristol-Myers Squibb Company
- Sanofi
- Hoffmann-La roche ltd.
- bluebird bio, inc.
- Novartis AG
- Uniqure NV.
Customers can also request for 10% free customization on this report.
“The North America region is expected to witness significant growth of Global Gene Therapy market due to the several government organizations supporting research campaigns around the country, owing to the robust regulatory framework for cellular treatment development and the substantial presence of biopharmaceutical businesses. Furthermore, the presence of modern healthcare infrastructure, availability of reimbursements, and the presence of significant industry players in the region is a key driver in shaping the future of this dynamic field. The key market players can expect profitable growth possibilities as research and development investments are rising at a rapid pace. In addition, the market players are implementing key marketing strategies for the growth and development of the gene therapy market during the forecast period” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.
“Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vector Type (Viral Vector, Non-Viral Vector), By Delivery Method (In-Vivo, Ex-Vivo), By Indication (Rare Diseases, Cancer, Neurological Diseases, Others), By Region & Competition, 2020-2030F”, has evaluated the future growth potential of Global Gene Therapy Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Gene Therapy Market.
Contact
TechSci Research LLC
420 Lexington Avenue,
Suite 300, New York,
United States- 10170
M: +13322586602